BELLETTI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.864
EU - Europa 5.493
AS - Asia 3.603
SA - Sud America 467
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 10
Totale 20.513
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.779
GB - Regno Unito 1.912
IT - Italia 1.719
CN - Cina 1.193
SG - Singapore 925
HK - Hong Kong 587
SE - Svezia 436
BR - Brasile 367
DE - Germania 324
TR - Turchia 264
UA - Ucraina 229
RU - Federazione Russa 217
VN - Vietnam 155
FI - Finlandia 142
FR - Francia 137
KR - Corea 117
IN - India 115
BG - Bulgaria 84
NL - Olanda 59
CA - Canada 49
AR - Argentina 42
JP - Giappone 37
ID - Indonesia 36
IE - Irlanda 36
ES - Italia 31
IR - Iran 31
BE - Belgio 26
RO - Romania 25
PL - Polonia 24
MX - Messico 22
PK - Pakistan 21
ZA - Sudafrica 21
BD - Bangladesh 20
IQ - Iraq 19
CH - Svizzera 16
IL - Israele 16
LT - Lituania 13
EC - Ecuador 12
CO - Colombia 11
AE - Emirati Arabi Uniti 10
GR - Grecia 10
CZ - Repubblica Ceca 9
EG - Egitto 9
EU - Europa 9
PT - Portogallo 9
MA - Marocco 8
UZ - Uzbekistan 8
VE - Venezuela 8
HU - Ungheria 7
PY - Paraguay 7
AT - Austria 6
CL - Cile 6
DZ - Algeria 6
NZ - Nuova Zelanda 6
PE - Perù 6
AZ - Azerbaigian 5
AU - Australia 4
BZ - Belize 4
EE - Estonia 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
SN - Senegal 4
TW - Taiwan 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
KE - Kenya 3
KH - Cambogia 3
KW - Kuwait 3
LK - Sri Lanka 3
MY - Malesia 3
NO - Norvegia 3
PH - Filippine 3
RS - Serbia 3
TN - Tunisia 3
YE - Yemen 3
BY - Bielorussia 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
NG - Nigeria 2
OM - Oman 2
PS - Palestinian Territory 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CG - Congo 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GN - Guinea 1
GY - Guiana 1
HR - Croazia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
Totale 20.504
Salva come PNG Salva come JPEG
Città #
Southend 1.526
Fairfield 1.078
Santa Clara 993
Ashburn 972
Woodbridge 706
Chandler 649
Hong Kong 583
Singapore 558
Jacksonville 456
Houston 454
Seattle 445
Wilmington 444
Dearborn 386
Ann Arbor 379
Cambridge 366
Hefei 328
Chicago 326
Nyköping 282
Beijing 276
Modena 236
London 222
Los Angeles 212
Izmir 157
Salt Lake City 96
New York 92
Princeton 91
Milan 89
San Diego 83
Sofia 82
Eugene 80
Council Bluffs 75
Seoul 75
Rome 70
The Dalles 60
Helsinki 57
Moscow 56
Redwood City 53
Bologna 52
Ho Chi Minh City 51
Dallas 49
Fremont 48
Falls Church 47
Elk Grove Village 44
Tampa 44
Shanghai 43
Buffalo 42
Munich 36
Bremen 35
São Paulo 33
Phoenix 32
Tokyo 32
Columbus 31
Dublin 31
Como 27
Napoli 26
Chennai 25
Frankfurt am Main 25
Jakarta 25
Brussels 23
Des Moines 23
Naples 23
Lancaster 22
San Giuliano Milanese 22
Hanoi 21
Reggio Emilia 21
Tulare 21
Florence 20
Guangzhou 20
Palermo 17
Miami 16
Norwalk 16
Sterling 16
Kocaeli 15
Nanjing 15
Stockholm 15
Boardman 14
Brooklyn 14
Genoa 14
Montreal 14
Orem 14
Perugia 14
Catania 13
Dulles 13
Parma 13
Bari 12
Boston 12
Johannesburg 12
Redondo Beach 12
Baghdad 11
Toronto 11
Warsaw 11
Changsha 10
Detroit 10
Halifax 10
Kunming 10
Pittsburgh 10
Poplar 10
Salerno 10
Turin 10
Atlanta 9
Totale 14.490
Salva come PNG Salva come JPEG
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 504
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 451
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 388
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 385
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 383
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 382
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 364
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 357
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 357
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 346
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 343
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 343
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 332
Nanomedicine: the future for advancing medicine and neuroscience 327
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 322
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 317
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 315
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 313
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 310
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 308
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 308
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 305
Nanoparticle transport across the blood brain barrier 304
Protein corona and nanoparticles: How can we investigate on? 300
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 298
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 298
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 294
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 292
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 286
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 285
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 278
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 276
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 276
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 274
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 269
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 267
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 266
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 263
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 257
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 257
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 256
Functionalization of liposomes: microscopical methods for preformulative screening 255
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 251
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 247
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 245
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 240
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 233
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 227
Blood-Brain Barrier crossing of high molecular weight molecules mediated by nanoparticles: a potential approach to treat neurological Lysosomal Storage Disorders 226
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 222
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 218
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 218
Immunonanosystems to CNS pathologies: State of the art 214
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine 214
Nanomedicine in Neuroscience: the potential of targeted nanoparticles in crossing the Blood-Brain Barrier 213
Nano-Neuroscience: Targeted nanoparticles For CNS drug delivery 209
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 208
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 207
Nanotechnology and Central Nervous System Drug Delivery 206
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 205
New perspectives in peptides- and antibodies- conjugated nanocarriers for brain delivery therapeutic purposes 203
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 199
TERAPIA NUTRIZIONALE PARENTERALE: APPROCCIO MULTIDISCIPLINARE, ORGANIZZATIVO E TECNOLOGICO 197
Rab5-dependent cell-specific uptake and distribution of engineered nanoparticles for CNS targeted drug delivery in vivo 196
NEUROTROPHIC FACTORS AND NEURODEGENERATIVE DISEASES: A DELIVERY ISSUE 195
Engineered nanoparticles for drug delivery to the CNS: in vivo experiments 188
Cholesterol nanoparticles partially rescue the alterations in synaptic phenotype of the R6/2 mouse model of Huntington's Disease 188
Leptin-conjugated nanoparticles as drug delivery system to the brain 184
Nanomedicine in Neuroscience: The potential of targeted nanoparticles in neurodegenerative disorders 171
Formulazione di siRNA anti blimp-1/PRDM in liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di LINFOMA EFFUSIVO PRIMARIO (pel) 163
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 160
Immunoliposome for the delivery of drugs and SiRNA for the treatment of cancer 156
Ligand- based strategies to modified NPs surface for blood-brain barrier crossing 152
Formulation and characterization of new Polymeric/Lipidic Hybrid systems for cidofovir delivery 151
Development and characterization of immunoliposomes for Cidofovir and SiRNA delivery: a new strategy for the treatment of Primary Effusion Lymphoma 147
Immunoliposomes to target the Primary Effusion Lymphoma (PEL): in vitro study 146
Corrigendum to: EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION (International Journal of Pharmaceutics (2016) 511 (1) (331-340) (S0378517316306512) (10.1016/j.ijpharm.2016.07.022)) 135
Nanomedicine in neurodegenerative disorders: Understanding the journey 124
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 122
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 116
Nanotechnology in medicine: therapeutic strategies in neurological disorders 113
Totale 20.720
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.164
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.164
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.527 0 0 0 0 0 174 199 307 113 494 144 96
2021/20221.693 100 156 169 79 55 102 103 112 190 145 277 205
2022/20231.840 201 225 155 182 201 240 55 186 206 29 75 85
2023/20241.333 72 66 91 98 298 139 145 172 37 39 59 117
2024/20253.723 170 54 62 287 765 520 279 307 335 161 354 429
2025/20263.525 436 214 456 876 1.382 161 0 0 0 0 0 0
Totale 20.720